Bausch & Lomb Recalls Muro 128 Ophthalmic Ointment Due to Crystallization
Bausch & Lomb is recalling Muro 128 ophthalmic ointment because crystals form in the product, causing a gritty feeling in the eye.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves physical irritation (gritty feeling) rather than a high-risk pathogen or structural defect causing serious injury.
Plain-English summary
Bausch & Lomb, Inc. is recalling Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%. The recall affects multiple package sizes, including 1 g tubes, 1/8 oz. tubes, and 1/4 oz. twin packs, distributed nationwide, in Puerto Rico, Canada, and Hong Kong.
The recall is being conducted because of crystal precipitate formation in the ointment. This defect has led to an increase in complaints from users experiencing a gritty, sand-like feeling in the eye.
Consumers should stop using the recalled product and contact Bausch & Lomb for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- MURO 128 (SODIUM CHLORIDE)
- Brand
- MURO 128
- Manufacturer
- Bausch & Lomb, Inc.
- Category
- Drug — Ophthalmic Ointment
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 179271
- Exp 08/14
- b) and c) 146791
- 146932
- Exp 06/14
- 151221
- 151922
- Exp 09/14
- 159102
- Exp 02/15
- 160912
- Exp 03/15
- 162422
- Exp 04/15
- 163641
- 05/15
- 166592
- Exp 07/15
- 169273
- Exp 09/15
UPCs (3)
- 0324208385562
- 324208385012
- 324208385555
Distribution
Part of a larger recall action
This product is one of 2 recalled by Bausch & Lomb, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Bausch & Lomb, Inc.
See all →- HighBausch + Lomb Stellaris Elite Vit Cutter Back Cap Separation Recall
FDA (Devices) · 2018-10-03
- HighBausch + Lomb Stellaris Elite Vit Cutter Back Cap Separation Recall
FDA (Devices) · 2018-10-03
- HighBausch + Lomb Stellaris Elite Vit Cutter Recall Due to Cap Separation
FDA (Devices) · 2018-10-03
- HighBausch + Lomb Stellaris Elite Vit Cutter Recall for Back Cap Separation
FDA (Devices) · 2018-10-03
- HighBausch + Lomb Stellaris Elite Vit Cutter Recall for Cap Separation
FDA (Devices) · 2018-10-03
Same hazard · crystallization
See all →- ModerateCyproheptadine Hydrochloride Syrup Recall Due to Precipitate
FDA (Drugs) · 2026-07-29
- HighBuprenorphine injection vials show crystallization identified as buprenorphine free base
FDA (Drugs) · 2026-06-24
- ModerateDapsone Gel Recalled Nationwide for Crystallization
FDA (Drugs) · 2025-01-08
- HighDapsone Topical Gel Recalled Due to Crystallization Defect
FDA (Drugs) · 2025-01-08
- ModerateOTC cough and congestion medication recalled for crystallization
FDA (Drugs) · 2024-11-13